Key References

Key References

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-121.

2. Ernst E, Koenig W. Fibrinogen and cardiovascular risk. Vasc Med 1997; 2: 115-125.

3. Danesh J, Collins R, Appleby P, Peto R. Fibrinogen, C-reactive protein, albumin, or white cell count: meta-analyses of prospective studies of coronary heart disease. JAMA 1998; 279: 1477-1482.

4. Haverkate F, Juhan-Vague I, van de Loo J, Thompson SG. Is the increase of fibrinogen as cardiovascular risk factor associated with acute phase reaction? In: Ernst E, Koenig W, Lowe GDO, Meade TW, eds. Fibrinogen: a "new" cardiovascular risk factor. Vienna: Blackwell-MZV, 1992:298-300.

5. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000; 321: 199-204.

6. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350: 430-436.

7. Muhlestein JB, Anderson JL, Hammond EH, Zhao L, Trehan S, Schwobe EP, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998; 97: 633-636.

8. Wald NJ, Law MR, Morris JK, Zhou X, Wong Y, Ward ME. Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study. BMJ 2000; 321: 204-207.

9. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ 2000; 321: 208-213.

10. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998; 97: 2007-2011.

11. Ridker PM, Rifai N, Stampfer M, Hennekens CH. Plasma concentrations of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767-1772.

12. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E, for the Cholesterol and Recurrent Events (CARE) Investigators. Elevation of tumor necrosis factor- and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101: 2149-2153.

13. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risk of future myocardial infarction in apparently healthy men. Lancet 1998; 351: 88-92.

14. Hwang S-J, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the atherosclerosis risk in communities (ARIC) study. Circulation 1997; 96: 4219-4225.

15. Griselli M, Herbert J, Hutchinson WL, Taylor KM, Sohail M, Krausz T, et al. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 1999; 190: 1733-1739.